2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of Pyridine-3-Carboxylic Acid as a Drug Carrier by Utilizing Multivariate Methods, Structure Property Correlations, and Pattern Recognition Techniques

Pages 61-71 | Received 20 Jan 2004, Accepted 25 Mar 2004, Published online: 04 Dec 2011

References

  • Anderberg, M. R. 1973. Cluster analysis for applications. New York. Academic Press, pp. 50–75.
  • Bartzatt, R. 2004. Drug Delivery 11(1):19–26.
  • Bartzatt, R., and Donigan, L. 2003. Receptors and Channels 9:309–313.
  • Bodor, N. 1999. Pharma Sciences 7(1):43–52.
  • Brewster,M., and Bodor,N. 1983. Journal of Parenteral Science and Technology 37(5):159–164.
  • Clark, D. 1999. Journal of Pharmaceutical Sciences 88(8):815–821.
  • Ertl, P., Rohde, B., and Selzer, P. 2000. J. Med. Chem. 43:3714–3717.
  • Gong, X., and Richman, M. B. 1995. J. Climate 8:897–931.
  • Goodman, L., and Gilman, A. 1970. The pharmacological basis of therapeutics. New York. Macmillan Corp, pp. 25–100.
  • Hansch, C., and Leo, A. 1995. Exploring QSAR. Washington D.C. ACS Professional Reference Book. Herrero, J., Valencia, A., and Dopazo, J. (2001). Bioinformatics 17:126–136.
  • Kelder, J., Grootenhuis, P. D. J., Bayada, D., Delbressine, L. P. C., and Ploemen, J. 1999. Pharmaceutical Research 16(10):1514–1519.
  • Linpinski, C. A., Lombardo, F., Dominy, B. W., and Feeney P. J. 1997. Adv. Drug Delivery Rev. 23:4–25.
  • Lipinski, C. A. 2000. Journal of Pharmacological and Toxicological Methods 44:235–249.
  • Molema, G., and Meijer D. 2001a. Drug targeting, pp. 23–35. New York: Wiley-VCH.
  • Molema, G., and Meijer D. 2001b. Drug targeting p. 35. NewYork(Wiley-VCH). Moriguchi, I., Hirono, S., Liu, Q., Nakagome, I., and Matsushita,Y. 1992. Chem. Phar. Bull. 40(1):127–130.
  • Palma, K., Luthman, K., Ungell, A., Strandlund, G., and Artursson, P. 1996. Journal of Pharmaceutical Sciences 85(1):32–39.
  • Palm, K., Stenberg, P., Luthman, K., and Artursson, P. 1997. Pharmaceutical Research 14(5):568–571.
  • Pop, E., Whei-Mei, W., and Nicholas, B. 1989a. J. Med. Chem. 32:1789–1795.
  • Pop, E., Whei-Mei,W., Shek, E., and Bodor N. 1989b. J. Med. Chem. 32:1774–1781.
  • Saunders, N. R., Habgood, M. D., and Dziegielewska, K. M. 1999. Clinical and Experimental Pharmacology and Physiology 26(1):11–19.
  • Sheha, M., Al-Tayeb, A., El-Sherief, H., and Farag, H. 2003. Bioorganic & Medicinal Chemistry 11(8):1865–1872.
  • Simpkins, J.W., Bahimy, M. H., and Bodor, N. 1991. Proc. Program Int. Symp. Controlled Release Bioact. Mater. 18:199–200.
  • Suglyama, Y., and Suzuki, H. 1987. Pharm Tech Japan 3(5):419–422.
  • Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., and Kopple, K. D. 2002. J. Med. Chem. 45:2615–2623.
  • Whei-Mei, W., Pop, E., Shek, E., and Bodor N. 1989. J. Med. Chem. 32:1782–1788.
  • Wimwood, D. 1989. Chemtracts: Organic Chemistry 2(4):239–242.
  • Woodard, P. A. 1990. Drug Design and Delivery 6(1):15–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.